- £5.68bn
- £6.19bn
- £3.04bn
- 95
- 34
- 69
- 77
2019 July 31st | 2020 July 31st | 2021 July 31st | 2022 July 31st | 2023 July 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2,498 | 2,548 | 2,406 | 2,566 | 3,037 |
Cost of Revenue | |||||
Gross Profit | 1,069 | 989 | 915 | 961 | 1,118 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 2,172 | 2,307 | 2,080 | 2,449 | 2,641 |
Operating Profit | 326 | 241 | 326 | 117 | 396 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 304 | 133 | 240 | 103 | 360 |
Provision for Income Taxes | |||||
Net Income After Taxes | 147 | 67 | 157 | 13 | 226 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 225 | 265 | 284 | 1,033 | 231 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 225 | 265 | 284 | 1,033 | 231 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.364 | 0.376 | 0.487 | 0.716 | 0.73 |
Dividends per Share |